A novel protein-engineered hepatocyte growth factor analog released via a shear-thinning injectable hydrogel enhances post-infarction ventricular function.

about

A novel protein-engineered hepatocyte growth factor analog released via a shear-thinning injectable hydrogel enhances post-infarction ventricular function.

Item

http://www.wikidata.org/entity/Q46567132

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A novel protein-engineered hep ...... farction ventricular function.

@en

A novel protein-engineered hep ...... farction ventricular function.

@nl

type

Item

label

A novel protein-engineered hep ...... farction ventricular function.

@en

A novel protein-engineered hep ...... farction ventricular function.

@nl

prefLabel

A novel protein-engineered hep ...... farction ventricular function.

@en

A novel protein-engineered hep ...... farction ventricular function.

@nl

P1476

A novel protein-engineered hep ...... nfarction ventricular function

@en

P2093

Aaron C Mitchell

http://www.w3.org/2001/XMLSchema#string

Abbygail A Foster

http://www.w3.org/2001/XMLSchema#string

Anahita Eskandari

http://www.w3.org/2001/XMLSchema#string

Andrew B Goldstone

http://www.w3.org/2001/XMLSchema#string

Bryan B Edwards

http://www.w3.org/2001/XMLSchema#string

Jennifer R Cochran

http://www.w3.org/2001/XMLSchema#string

Laura M Marquardt

http://www.w3.org/2001/XMLSchema#string

Lei Cai

http://www.w3.org/2001/XMLSchema#string

Sarah C Heilshorn

http://www.w3.org/2001/XMLSchema#string

Vi N Truong

http://www.w3.org/2001/XMLSchema#string

P2860

Biomaterials to enhance stem cell function in the heart

Novel therapy for myocardial infarction: can HGF/Met be beneficial?

Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association

Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction.

Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model

Engineering hepatocyte growth factor fragments with high stability and activity as Met receptor agonists and antagonists.

Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction

Cardiac cell therapy: where we've been, where we are, and where we should be headed.

Injectable multidomain peptide nanofiber hydrogel as a delivery agent for stem cell secretome.

A comparison of methods for quantifying angiogenesis in the Matrigel assay in vitro

P304

2379-2389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BIT.26345

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Amanda N Steele

P577

2017-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28574594

http://www.w3.org/2001/XMLSchema#string

P921

hydrogel

P932

5947314

http://www.w3.org/2001/XMLSchema#string